Porter L P, McNamee J E, Wolf M B
Department of Science, Midlands Technical College, Columbia, SC, USA.
Microcirculation. 2000 Oct;7(5):347-56.
To determine the interactions of endothelin-1 (ET-1) and nitric oxide (NO) in the regulation of endothelial barrier function in skeletal muscle.
The protein sieving coefficient (1 - sigma f) was measured as an index of microvascular permeability in the isolated, perfused cat hindlimb preparation. The measurement was made to determine 1) the effects of ET-1 and NO on basal permeability by blocking the ETA receptor with BQ123 and NO production with the NO-synthase inhibitors L-NAME or L-NMMA; 2) if elevated NO (SNAP) affects permeability; and 3) the interaction of ET-1 and NO by ascertaining if NO-synthase inhibition or elevated NO can block the ET-1-induced permeability increases. Additionally, vascular resistance was determined under these conditions to see if increased microvascular pressures or increased shear stress might play a role in the permeability changes.
Blocking either the ETA receptor or basal NO production did not affect basal permeability. Likewise, raising NO levels did not affect this permeability. Blocking the ETA receptor blocked the ability of ET-1 to cause a profound barrier failure. Increased NO also could block this ET-1-induced effect. Blocking the ETA receptor or elevating NO blocked the 2.5-fold increase in vascular resistance induced by ET-1.
Since the ETA receptor does not reside on skeletal muscle endothelium, it is not likely that ET-1 acts directly on the endothelium to produce its effects. It could act through 1) increases in shear stress secondary to an ET-1-induced vasoconstriction; 2) ET-1-induced increases in microvascular pressure sufficient to cause an inflammatory reaction; or 3) stimulation of other cell types, such as leukocytes, to release inflammatory mediators that could damage the endothelium.
确定内皮素 -1(ET -1)与一氧化氮(NO)在调节骨骼肌内皮屏障功能中的相互作用。
在分离灌注的猫后肢标本中,测量蛋白质筛滤系数(1 - σf)作为微血管通透性指标。进行该测量以确定:1)用BQ123阻断ETA受体以及用一氧化氮合酶抑制剂L - NAME或L - NMMA抑制NO生成时,ET -1和NO对基础通透性的影响;2)升高的NO(SNAP)是否影响通透性;3)通过确定一氧化氮合酶抑制或升高的NO是否能阻断ET -1诱导的通透性增加来研究ET -1与NO的相互作用。此外,在这些条件下测定血管阻力,以观察微血管压力增加或剪切应力增加是否可能在通透性变化中起作用。
阻断ETA受体或基础NO生成均不影响基础通透性。同样,升高NO水平也不影响该通透性。阻断ETA受体可阻断ET -1导致严重屏障破坏的能力。增加的NO也可阻断这种ET -1诱导的效应。阻断ETA受体或升高NO可阻断ET -1诱导的血管阻力2.5倍的增加。
由于ETA受体不存在于骨骼肌内皮细胞上,ET -1不太可能直接作用于内皮细胞来产生其效应。它可能通过以下方式起作用:1)ET -1诱导血管收缩继发的剪切应力增加;2)ET -1诱导的微血管压力增加足以引发炎症反应;或3)刺激其他细胞类型,如白细胞,释放可能损伤内皮的炎症介质。